These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 7515979

  • 21. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
    Fauchier JP, Cosnay P, Rouesnel P, Moquet B, Bonnet P, Scala PJ, Demeyer JF.
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264
    [Abstract] [Full Text] [Related]

  • 22. [Electrophysiologic effects of intravenous carocainide].
    Zannad F, Aliot E, Baille N, Gilgenkrantz JM.
    Arch Mal Coeur Vaiss; 1986 Feb; 79(2):236-41. PubMed ID: 3085623
    [Abstract] [Full Text] [Related]

  • 23. Effects of N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate on the ventriculo-atrial conductivity of accessory pathways.
    Satoh S, Watanabe J, Keitoku M, Kinoshita H, Sekiguchi N, Endoh S, Ohtsuka K, Hangai K, Morita M, Takishima T.
    Arzneimittelforschung; 1989 Aug; 39(8):908-11. PubMed ID: 2818680
    [Abstract] [Full Text] [Related]

  • 24. [Analysis of changes in repolarization for the differential diagnosis of narrow QRS supraventricular tachycardia and the site of the accessory pathway].
    Fassini G, Riva S, Della Bella P, Carbucicchio C, Tondo C.
    Cardiologia; 1996 Sep; 41(9):869-75. PubMed ID: 8983843
    [Abstract] [Full Text] [Related]

  • 25. [Electrophysiological effects and antiarrhythmic activity of novel domestic class III antiarrhythmogenic drug niferidil administered in patients with paroxismal supraventricular tachycardia].
    Mironov NIu, Golitsyn SP, Sokolov SF, Maĭkov EB, Shlevkov NB, Iuricheva IuA, Mareev IuV, Rosenshtraukh LV, Chazov EI.
    Eksp Klin Farmakol; 2012 Sep; 75(10):16-21. PubMed ID: 23240154
    [Abstract] [Full Text] [Related]

  • 26. [Clinico-electrophysiologic effects of magnesium, especially in supraventricular tachycardia].
    Vester EG.
    Herz; 1997 Jun; 22 Suppl 1():40-50. PubMed ID: 9333591
    [Abstract] [Full Text] [Related]

  • 27. [Electrophysiological testing of multiple antiarrhythmic drugs in patients with paroxysmal supraventricular tachycardia after chronic oral administration].
    Nishino T.
    Hokkaido Igaku Zasshi; 1989 Nov; 64(6):738-48. PubMed ID: 2606448
    [Abstract] [Full Text] [Related]

  • 28. Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction.
    Kułakowski P, Karczmarewicz S, Karpiński G, Soszyńska M, Ceremuzyński L.
    Europace; 2000 Jul; 2(3):207-15. PubMed ID: 11227590
    [Abstract] [Full Text] [Related]

  • 29. [Electrophysiologic effects and clinical efficacy of propafenone in pediatric patients with paroxysmal supraventricular reentrant tachycardia].
    Musto B, D'Onofrio A, Musto A, Cavallaro C, Marsico F.
    G Ital Cardiol; 1986 Apr; 16(4):336-43. PubMed ID: 3743937
    [Abstract] [Full Text] [Related]

  • 30. [Electrophysiologic effects of intravenous flecainide in intranodal junctional tachycardia in 30 patients].
    Haissaguerre M, Warin JF, Goldrach S, Le Métayer P, Guillem JP, Blanchot P.
    Arch Mal Coeur Vaiss; 1988 Dec; 81(12):1493-8. PubMed ID: 3147639
    [Abstract] [Full Text] [Related]

  • 31. Electrophysiologic effects of E-4031, a class III antiarrhythmic agent, on re-entrant ventricular arrhythmias in a canine 7-day-old myocardial infarction model.
    Katoh H, Ogawa S, Furuno I, Sato Y, Yoh S, Saeki K, Nakamura Y.
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1077-82. PubMed ID: 2359016
    [Abstract] [Full Text] [Related]

  • 32. Accessory pathway reciprocating tachycardia.
    Obel OA, Camm AJ.
    Eur Heart J; 1998 May; 19 Suppl E():E13-24, E50-1. PubMed ID: 9717020
    [Abstract] [Full Text] [Related]

  • 33. Clinical, electrophysiologic and antiarrhythmic efficacy of moricizine HCl.
    Smetnev AS, Shugushev KKh, Rosenshtraukh LV.
    Am J Cardiol; 1987 Oct 16; 60(11):40F-44F. PubMed ID: 3310584
    [Abstract] [Full Text] [Related]

  • 34. [Evaluation of the clinical acute electrophysiological effects of propafenone using transesophageal atrial pacing].
    He F, Zhao X, Cheng X.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun 16; 16(3):239-41. PubMed ID: 7528645
    [Abstract] [Full Text] [Related]

  • 35. [Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia].
    Brandão L, de Sousa J, Barreiros MC, Vagueiro MC, Amram SS.
    Rev Port Cardiol; 1994 Mar 16; 13(3):197-202, 191. PubMed ID: 8049086
    [Abstract] [Full Text] [Related]

  • 36. [Terminating supraventricular tachycardia with adenosine--comparing the effectiveness of 12 mg and 18 mg].
    Weismüller P, Kattenbeck K, Heinroth KM, Ranke C, Trappe HJ.
    Dtsch Med Wochenschr; 2000 Aug 18; 125(33):961-9. PubMed ID: 10994404
    [Abstract] [Full Text] [Related]

  • 37. Electrophysiology and long-term efficacy of pentisomide in patients with supraventricular tachycardia.
    Kühlkamp V, Mewis C, Seipel L.
    Int J Cardiol; 1992 Jul 18; 36(1):69-79. PubMed ID: 1428255
    [Abstract] [Full Text] [Related]

  • 38. Electrophysiologic effects and antiarrhythmic efficacy of recainam in patients with supraventricular tachycardia.
    Tai YT, Campbell RW, McComb JM.
    J Cardiovasc Pharmacol; 1991 Feb 18; 17(2):310-5. PubMed ID: 1709237
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Hemodynamic and electrophysiologic effects of the new calcium antagonist Ro 11-1781 (author's transl)].
    Bödeker K, Bischoff KO, Menken U, Hager W.
    Z Kardiol; 1980 Nov 18; 69(11):790-6. PubMed ID: 7467662
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.